Venous Thromboembolism News and Research

RSS

Statins show promise for deep vein thrombosis

Statins, the class of drugs commonly used for lowering cholesterol, are now showing promise at preventing deep vein thrombosis (DVT) or blood clots, an affliction that occurs in nearly 2 million Americans each year.

27 Oct 2008

Danish study provides new information on hormone replacement therapy and the risk of heart attacks

It's not what you take but the way that you take it that can produce different results in women who take hormone replacement therapy (HRT), according to new research on the association between HRT and heart attacks, published online in Europe's leading cardiology journal, the European Heart Journal today.

30 Sep 2008

Hospital patients to be assessed for risk of venous thromboembolism

Sir Liam Donaldson, Chief Medical Officer, announced today the publication of a risk assessment for venous thromboembolism, recommended for all patients admitted to hospital in England.

21 Sep 2008

Maternal deaths following cesarean delivery can be reduced

Maternal death rates have remained constant in the United States for many decades. Are there any improvements in health care that could reduce these rates further?

4 Aug 2008

New evidence-based blood clot guidelines for pregnant women

New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies.

24 Jun 2008

No link between aromatase inhibitors and cardiovascular problems

New evidence has emerged that, contrary to some current fears, aromatase inhibitors (AIs) are not associated with an increased risk of heart problems in women who take them to prevent their breast cancer recurring.

17 Apr 2008

Anemia drug linked to blood clots, death in cancer patients

Treating anemia with a class of drugs known as erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs) and death among patients with cancer, according to an article in the February 27 issue of JAMA: The Journal of the American Medical Association.

27 Feb 2008

Extra warning of blood clot risk with contraceptive skin patch

Drug regulators in the United States have granted approval for an additional warning to be added to the label of a popular contraceptive patch.

21 Jan 2008

Label change for Ortho Evra Contraceptive Transdermal Patch

The U.S. Food and Drug Administration (FDA) has approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills.

21 Jan 2008

Study examines computed tomographic pulmonary angiography for diagnosing blood clots in the lung

New research indicates that a diagnostic strategy using computed tomographic pulmonary angiography (CTPA) may be a safe alternative to conventional lungs scans (known as ventilation-perfusion scans) for excluding the diagnosis of pulmonary embolism (blood clots in the lung vessels), although CTPA may detect more clots, according to a study in the current issue of JAMA: The Journal of the American Medical Association.

20 Dec 2007

HHS releases new tools with aim to make health care safer

An array of toolkits designed to help doctors, nurses, hospital managers, patients and others reduce medical errors was released by HHS' Agency for Healthcare Research and Quality.

17 Dec 2007

New studies add weight to link between pre-eclampsia and heart disease

Two studies, published together on bmj.com, add further weight to the theory that pre-eclampsia and cardiovascular diseases may share common causes or mechanisms.

2 Nov 2007

Phase 3 study on novel oral direct thrombin inhibitor

Boehringer Ingelheim has announced that the September 15 issue of The Lancet will publish results from the RE-NOVATE study, which investigated dabigatran etexilate as a potential therapy for patients undergoing total hip replacement surgery.

13 Sep 2007

Jump in cancer-related clots

Blood clots are increasingly common in cancer patients, but University of Rochester Medical Center researchers have created a novel risk model that can predict, with 98 percent certainty, which patients will not get a blood clot.

3 Aug 2007

Studies assess blood clot prevalence outside hospital prevention in hospital

More cases of venous thromboembolism are diagnosed in the three months following hospitalization than during hospitalization, but less than half of inpatients receive medications to prevent blood clots from occurring, according to a report in the July 23 issue of Archives of Internal Medicine.

24 Jul 2007

Venous thromboembolism in the U.S.

Venous thrombosis (VTE), the formation of blood clots in a vein, is a major health problem for hospitalized patients in the United States.

16 Jul 2007

Four hours in ecomony class doubles the risk for deep vein thrombosis

According to the World Health Organization (WHO) the chances of developing deep vein thrombosis ( DVT) double after traveling for four hours or more; this says WHO equates to one in 6,000 long-haul passengers at risk of potentially dangerous blood clots.

2 Jul 2007

Venous thromboembolis accounts for 10% of all hospital deaths

Up to 25,000 people may die needlessly each year due to the failure to prevent blood clots known as venous thromboembolisms (VTE) in UK hospitals, say experts in this week's BMJ.

18 May 2007

Merits and risks of postmenopausal hormone therapy

The study was categorized as a primary prevention trial for coronary heart disease, although the fact that mean age at recruitment was 63 years was not given enough importance at that time. WHI investigators concluded that hormone therapy (HT) was not cardioprotective, and, in fact, its riskbenefit ratio did not favor the use of postmenopausal hormones for prevention of chronic diseases.

17 May 2007

FDA approves new indication for FRAGMIN for the extended treatment of symptomatic venous thromboembolism

The U.S. Food and Drug Administration (FDA) has approved a new indication for FRAGMIN (dalteparin sodium injection), for the extended treatment of symptomatic venous thromboembolism (VTE) to reduce the recurrence of VTE in patients with cancer.

4 May 2007